Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Other financing activities (2022 - 2024)

Bio Essence has reported Other financing activities over the past 3 years, most recently at -$9323.0 for Q1 2024.

  • For Q1 2024, Other financing activities fell 198.09% year-over-year to -$9323.0; the TTM value through Dec 2024 reached -$9323.0, up 86.32%, while the annual FY2024 figure was -$9323.0, 86.32% up from the prior year.
  • Other financing activities for Q1 2024 was -$9323.0 at Bio Essence, up from -$20395.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $9505.0 in Q1 2023 and troughed at -$71732.0 in Q4 2022.
  • A 3-year average of -$20840.6 and a median of -$9323.0 in 2024 define the central range for Other financing activities.
  • Biggest five-year swings in Other financing activities: surged 71.57% in 2023 and later crashed 198.09% in 2024.
  • Year by year, Other financing activities stood at -$71732.0 in 2022, then surged by 71.57% to -$20395.0 in 2023, then skyrocketed by 54.29% to -$9323.0 in 2024.
  • Business Quant data shows Other financing activities for BIOE at -$9323.0 in Q1 2024, -$20395.0 in Q4 2023, and $2267.0 in Q3 2023.